Cargando…
Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis
BACKGROUND: The purpose of the present research is to analyze the effect of polyphenols and flavonoids substrat (PFS) from plants Calendula officinalis, Salvia fruticosa, Achillea millefolium, and propolis as immunomodulatory in the production of interleukin (IL)-1β and IL-10 in peripheral blood leu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792512/ https://www.ncbi.nlm.nih.gov/pubmed/31586435 http://dx.doi.org/10.12659/MSM.915464 |
_version_ | 1783459172425138176 |
---|---|
author | Gleiznys, Darius Gleiznys, Alvydas Abraškevičiūtė, Lina Vitkauskienė, Astra Šaferis, Viktoras Sakalauskienė, Jurgina |
author_facet | Gleiznys, Darius Gleiznys, Alvydas Abraškevičiūtė, Lina Vitkauskienė, Astra Šaferis, Viktoras Sakalauskienė, Jurgina |
author_sort | Gleiznys, Darius |
collection | PubMed |
description | BACKGROUND: The purpose of the present research is to analyze the effect of polyphenols and flavonoids substrat (PFS) from plants Calendula officinalis, Salvia fruticosa, Achillea millefolium, and propolis as immunomodulatory in the production of interleukin (IL)-1β and IL-10 in peripheral blood leukocytes medium (PBLM) in patients who were diagnosed with mucositis of peri-implant tissue compared to patients with healthy implant tissue. It was hypothesized that IL-1β and IL-10 contribute to the inflammation processes noticed in the diseases of peri-implant tissues. MATERIAL/METHODS: Sixty non-smoking patients were included in this study: patients with healthy implants (HP group) and patients with peri-implant mucositis (MP group). Peri-mucositis was diagnosed by radiologic and clinical examination. The PBLM from MP were treated with PFS at various concentrations. The levels of IL-10 and IL-1β excreted by the PBLM stimulated and unstimulated with viable Porphyromonas gingivalis test-tube were committed by the enzyme amplified immunoassay sensitivity method. RESULTS: Unstimulated and stimulated PBLM and treatment with 5.0 mg/mL or 10.0 mg/mL of PFS in the MP group produced significantly higher levels IL-10 (P<0.001) that analogous mediums of the HP group. The levels of IL-1β decreased more considerably in the stimulated PBLM of the MP group than in those of HP group (P<0.001) after the treatment with PFS at only 10.0 mg/mL concentration. CONCLUSIONS: Theses results suggest that the solution of PFS might offer a new potential for the development of a new therapeutic path to prevent and treat peri-implant mucositis. |
format | Online Article Text |
id | pubmed-6792512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67925122019-10-31 Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis Gleiznys, Darius Gleiznys, Alvydas Abraškevičiūtė, Lina Vitkauskienė, Astra Šaferis, Viktoras Sakalauskienė, Jurgina Med Sci Monit Clinical Research BACKGROUND: The purpose of the present research is to analyze the effect of polyphenols and flavonoids substrat (PFS) from plants Calendula officinalis, Salvia fruticosa, Achillea millefolium, and propolis as immunomodulatory in the production of interleukin (IL)-1β and IL-10 in peripheral blood leukocytes medium (PBLM) in patients who were diagnosed with mucositis of peri-implant tissue compared to patients with healthy implant tissue. It was hypothesized that IL-1β and IL-10 contribute to the inflammation processes noticed in the diseases of peri-implant tissues. MATERIAL/METHODS: Sixty non-smoking patients were included in this study: patients with healthy implants (HP group) and patients with peri-implant mucositis (MP group). Peri-mucositis was diagnosed by radiologic and clinical examination. The PBLM from MP were treated with PFS at various concentrations. The levels of IL-10 and IL-1β excreted by the PBLM stimulated and unstimulated with viable Porphyromonas gingivalis test-tube were committed by the enzyme amplified immunoassay sensitivity method. RESULTS: Unstimulated and stimulated PBLM and treatment with 5.0 mg/mL or 10.0 mg/mL of PFS in the MP group produced significantly higher levels IL-10 (P<0.001) that analogous mediums of the HP group. The levels of IL-1β decreased more considerably in the stimulated PBLM of the MP group than in those of HP group (P<0.001) after the treatment with PFS at only 10.0 mg/mL concentration. CONCLUSIONS: Theses results suggest that the solution of PFS might offer a new potential for the development of a new therapeutic path to prevent and treat peri-implant mucositis. International Scientific Literature, Inc. 2019-10-05 /pmc/articles/PMC6792512/ /pubmed/31586435 http://dx.doi.org/10.12659/MSM.915464 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Clinical Research Gleiznys, Darius Gleiznys, Alvydas Abraškevičiūtė, Lina Vitkauskienė, Astra Šaferis, Viktoras Sakalauskienė, Jurgina Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis |
title | Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis |
title_full | Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis |
title_fullStr | Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis |
title_full_unstemmed | Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis |
title_short | Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis |
title_sort | interleukin-10 and interleukin-1β cytokines expression in leukocytes of patients with chronic peri-mucositis |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792512/ https://www.ncbi.nlm.nih.gov/pubmed/31586435 http://dx.doi.org/10.12659/MSM.915464 |
work_keys_str_mv | AT gleiznysdarius interleukin10andinterleukin1bcytokinesexpressioninleukocytesofpatientswithchronicperimucositis AT gleiznysalvydas interleukin10andinterleukin1bcytokinesexpressioninleukocytesofpatientswithchronicperimucositis AT abraskeviciutelina interleukin10andinterleukin1bcytokinesexpressioninleukocytesofpatientswithchronicperimucositis AT vitkauskieneastra interleukin10andinterleukin1bcytokinesexpressioninleukocytesofpatientswithchronicperimucositis AT saferisviktoras interleukin10andinterleukin1bcytokinesexpressioninleukocytesofpatientswithchronicperimucositis AT sakalauskienejurgina interleukin10andinterleukin1bcytokinesexpressioninleukocytesofpatientswithchronicperimucositis |